Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2005 September;17(3) > Minerva Biotecnologica 2005 September;17(3):107-17

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA BIOTECNOLOGICA

A Journal on Biotechnology and Molecular Biology


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246


eTOC

 

  MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE


Minerva Biotecnologica 2005 September;17(3):107-17

language: English

Oligosaccharides engineering from plants and algae applications in biotechnology and therapeutics

Delattre C., Michaud P., Courtois B., Courtois J.

Laboratory of Glucides-EPMV CNRS FRE 2779, IUT/GB, UPJV, Amiens, France


Full text temporarily not available online. Contact us  


Since the last decade, newly observed functions of oligosaccharides are their ability to act as regulatory molecules on various organisms. The successful development of these compounds in future implies efficient processes for specific oligosaccharide production. For this reason, plant and algae constitute an original source of various oligosaccharidic structures. To exploit them, two strategies are available: synthesis (chemical or by enzymes) and polysaccharide cleavage (chemical, physical or biological). This review catalogues the possibilities of these methods, applied to plant and algae polysaccharide models, to generate bioactive oligosaccharides.

top of page

Publication History

Cite this article as

Corresponding author e-mail